
    
      The use of high-dose bolus glucocorticoids in the treatment of patients with COVID-19
      infection will increase the anti-inflammatory effect without increasing side effects. This
      will allow a better patient outcome, reducing the number of deaths and the need for
      intubation or admission to the Intensive Care Unit.
    
  